Search
Now showing items 1-2 of 2
Assessing the potential of pharmaceuticals and their transformation products to cause mutagenic effects: Implications for gene expression profiling
(2016)
The selection and prioritization of pharmaceuticals and their transformation products for evaluating effects on the environment and human health is a challenging task. One common approach is based on compounds (e.g., mixture ...
Biodegradation potential of ofloxacin and its resulting transformation products during photolytic and photocatalytic treatment
(2013)
The release of pharmaceuticals in the environment, as parent compounds, metabolites and transformation products, and the consequent risks posed to living organisms due to the unintended exposure of the latter to these ...